Budgetary Impact of Bendamustine Ready-to-Dilute Products in Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma to a United States Infusion Facility

Hodgkin Lymphoma ◽

Lymphocytic Leukemia ◽

Budgetary Impact ◽

To Evaluate the Safety and Tolerability, Find an Appropriate Dose to Optimize Safety and Efficacy, and Evaluate Clinical Activity of PBCAR20A in Subjects With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) or r/r Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)

Case Medical Research ◽

10.31525/ct1-nct04030195 ◽

2019 ◽

Author(s):

Keyword(s):

Hodgkin Lymphoma ◽

Lymphocytic Leukemia ◽

Clinical Activity ◽

Small Lymphocytic Lymphoma ◽

Safety And Efficacy ◽

Faculty Opinions recommendation of Serum-free light chain-a new biomarker for patients with B-cell non-Hodgkin lymphoma and chronic lymphocytic leukemia.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1072097.525084 ◽

2007 ◽

Author(s):

Emili Montserrat

Keyword(s):

B Cell ◽

Hodgkin Lymphoma ◽

Light Chain ◽

Free Light Chain ◽

Lymphocytic Leukemia ◽

Serum Free ◽

Serum Free Light Chain ◽

Therapy-related myelodysplastic syndrome/acute myeloid leukemia following fludarabine therapy for non-Hodgkin lymphoma and chronic lymphocytic leukemia in Thai patients

Leukemia & Lymphoma ◽

10.3109/10428194.2010.505675 ◽

2010 ◽

Vol 51 (11) ◽

pp. 2120-2125 ◽

Cited By ~ 5

Author(s):

Pimjai Niparuck ◽

Wasana Kanoksil ◽

Suporn Chuncharunee ◽

Paisarn Boonsakan ◽

Artit Ungkanont ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Myelodysplastic Syndrome ◽

Hodgkin Lymphoma ◽

Myeloid Leukemia ◽

Lymphocytic Leukemia ◽

Non Hodgkin Lymphoma ◽

Acute Myeloid

Subcutaneous rituximab with recombinant human hyaluronidase in the treatment of non-Hodgkin lymphoma and chronic lymphocytic leukemia

Future Oncology ◽

10.2217/fon-2017-0574 ◽

2018 ◽

Vol 14 (17) ◽

pp. 1691-1699 ◽

Cited By ~ 1

Author(s):

Samuel Luke Hill ◽

Andrew Davies

Keyword(s):

Hodgkin Lymphoma ◽

Lymphocytic Leukemia ◽

Non Hodgkin Lymphoma ◽

Recombinant Human Hyaluronidase

Phase II Study of Interleukin-4 in Indolent B-cell Non-Hodgkin Lymphoma and B-cell Chronic Lymphocytic Leukemia: A Study of the Eastern Cooperative Oncology Group (E5Y92)

Journal of Immunotherapy ◽

10.1097/cji.0b013e3181f5dfc5 ◽

2010 ◽

Vol 33 (9) ◽

pp. 1006-1009 ◽

Cited By ~ 5

Author(s):

Peter H. Wiernik ◽

Janice P. Dutcher ◽

Xiapan Yao ◽

Usha Venkatraj ◽

Carla I. Falkson ◽

...

Keyword(s):

B Cell ◽

Hodgkin Lymphoma ◽

Phase Ii Study ◽

Eastern Cooperative Oncology Group ◽

Lymphocytic Leukemia ◽

Interleukin 4 ◽

Oncology Group ◽

Non Hodgkin Lymphoma ◽

Cell Chronic Lymphocytic Leukemia

Circulating CD44 and intercellular adhesion molecule-1 levels in low grade non-Hodgkin lymphoma and B-cell chronic lymphocytic leukemia patients during interferon-?-2a treatment

Cancer ◽

10.1002/1097-0142(20001001)89:7<1474::aid-cncr9>3.0.co;2-c ◽

2000 ◽

Vol 89 (7) ◽

pp. 1474-1481 ◽

Cited By ~ 6

Author(s):

Meral Beksa� ◽

Mutlu Arat ◽

Hamdi Akan ◽

Haluk Ko� ◽

Osman Ilhan ◽

...

Keyword(s):

B Cell ◽

Hodgkin Lymphoma ◽

Adhesion Molecule ◽

Lymphocytic Leukemia ◽

Intercellular Adhesion Molecule ◽

Low Grade ◽

Intercellular Adhesion Molecule 1 ◽

Non Hodgkin Lymphoma ◽

Cell Chronic Lymphocytic Leukemia

Pharmacokinetics of Venetoclax, a Novel BCL-2 Inhibitor, in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Non-Hodgkin Lymphoma

The Journal of Clinical Pharmacology ◽

10.1002/jcph.821 ◽

2016 ◽

Vol 57 (4) ◽

pp. 484-492 ◽

Cited By ~ 50

Author(s):

Ahmed Hamed Salem ◽

Suresh K. Agarwal ◽

Martin Dunbar ◽

Sari L. Heitner Enschede ◽

Rod A. Humerickhouse ◽

...

Keyword(s):

Hodgkin Lymphoma ◽

Lymphocytic Leukemia ◽

III. Role of allotransplantation for non-Hodgkin lymphoma and chronic lymphocytic leukemia

Annals of Oncology ◽

10.1093/annonc/mdr169 ◽

2011 ◽

Vol 22 ◽

pp. iv36-iv39 ◽

Cited By ~ 2

Author(s):

P. Dreger

Keyword(s):

Hodgkin Lymphoma ◽

Lymphocytic Leukemia ◽

CD49 Expression in Chronic Lymphocytic Leukemia B-Cell and Non-Hodgkin Lymphoma

The Medical Journal of Cairo University ◽

10.21608/mjcu.2018.57496 ◽

2018 ◽

Vol 86 (9) ◽

pp. 2169-2176

Author(s):

DALIA IBRAHIM, M.D.; ABEER FAROUK, M.D.

Keyword(s):

B Cell ◽

Hodgkin Lymphoma ◽

Lymphocytic Leukemia ◽

212Pb-NNV003 as a Novel Targeted Alpha Therapy for CD37 Positive B-cell Chronic Lymphocytic Leukemia (CLL) and Non-Hodgkin Lymphoma (NHL)

Journal of Medical Imaging and Radiation Sciences ◽

10.1016/j.jmir.2019.11.030 ◽

2019 ◽

Vol 50 (4) ◽

pp. S74-S75

Author(s):

Amal Saidi ◽

Astri Maaland ◽

Julien Torgue ◽

Helen Heyerdah ◽

Jostein Dahle

Keyword(s):

B Cell ◽

Hodgkin Lymphoma ◽

Lymphocytic Leukemia ◽

Targeted Alpha Therapy ◽

Non Hodgkin Lymphoma ◽

Alpha Therapy ◽

Cell Chronic Lymphocytic Leukemia